The Proper Use of Thyroid Medication in Bodybuilding

Thyroid hormones play a critical role in metabolism, energy expenditure, and overall physiological function. In bodybuilding, particularly in untested federations where pharmacological aids are utilised, thyroid medication is sometimes introduced to manage metabolic adaptations during a dieting phase. However, improper use can lead to serious health risks, including long-term suppression of endogenous thyroid function and excessive muscle catabolism. This article outlines the appropriate use of thyroid medication, explains the physiological downregulation of thyroid function during dieting, and highlights the risks of its misuse.

Understanding Thyroid Function and Its Role in Metabolism

The thyroid gland produces two key hormones: thyroxine (T4) and triiodothyronine (T3). T4 is the precursor hormone, which is converted into T3, the active form responsible for regulating metabolic rate. The production of these hormones is controlled by the hypothalamic-pituitary-thyroid (HPT) axis. The hypothalamus releases thyrotropin-releasing hormone (TRH), which stimulates the pituitary gland to release thyroid-stimulating hormone (TSH). TSH then acts on the thyroid gland to produce T4 and T3. The levels of these hormones are regulated via a negative feedback loop; when T3 and T4 levels are sufficient, TSH production is suppressed, preventing excessive thyroid hormone secretion.

The conversion of T4 to T3 is controlled by deiodinase enzymes:

Deiodinase 1 (D1): Converts T4 to T3 in the liver and peripheral tissues.
Deiodinase 2 (D2): Regulates local T3 levels in tissues like the brain, muscle, and brown adipose tissue.
Deiodinase 3 (D3): Converts T4 to reverse T3 (rT3), an inactive form that downregulates metabolism.

When calorie intake is reduced for prolonged periods, the body downregulates thyroid hormone activity as a protective mechanism to conserve energy. This occurs via a reduction in D1 and D2 activity, decreasing T3 availability, and an increase in D3 activity, raising rT3 levels (1). This metabolic adaptation is a normal response to energy restriction but can negatively impact fat loss, energy levels, and overall well-being in extreme cases.

Proper Use of Thyroid Medication in Bodybuilding

For untested competitors, thyroid medication may be used strategically to counteract the decline in endogenous thyroid function that occurs towards the end of a dieting phase. The key principles for responsible use include:

Supplementing Physiological Decline: The primary purpose should be to restore thyroid levels to what would be expected in a eucaloric (maintenance-calorie) state. This helps maintain metabolic rate without pushing the body into excessive hyperthyroidism.
Using Physiological Doses: A common approach is to use a low dose of T3 (e.g., 12.5–25 mcg/day) or a combination of T4 and T3 to mimic normal thyroid function. This prevents excessive muscle loss and other adverse effects associated with hyperthyroidism.
Introducing Only When Endogenous Production Declines: Thyroid medication should only be considered when objective markers (e.g., blood tests showing suppressed T3/free T3) confirm downregulation. This usually occurs after prolonged calorie restriction rather than in the early stages of dieting.
Monitoring and Post-Diet Recovery: If thyroid medication is used, a gradual tapering approach post-competition is advisable to allow endogenous production to recover.

Improper Use of Thyroid Medication

Improper use of thyroid medication is common among bodybuilders who seek to accelerate fat loss without making necessary adjustments to diet and training. The main forms of misuse include:

Using Beyond Physiological Doses: Supraphysiological doses (e.g., >50 mcg T3/day) push the body into a hyperthyroid state, leading to excessive calorie burning, muscle catabolism, and cardiovascular stress. This can also result in long-term suppression of the thyroid gland, making post-competition recovery difficult.
Using Too Early in a Dieting Phase: If thyroid medication is introduced before endogenous downregulation occurs, it becomes an unnecessary crutch that replaces normal adaptations to dieting. A well-structured nutrition plan should be the first line of intervention.
Using as an Alternative to Diet and Training Adjustments: Some athletes use thyroid medication to avoid further reductions in calories or increases in cardio. While this may seem appealing, it bypasses the fundamental principles of fat loss and can lead to metabolic instability post-diet.

Risks and Long-Term Consequences

The misuse of thyroid medication can have serious consequences, including:

Muscle Loss: Excess T3 increases protein breakdown, leading to significant muscle catabolism if not balanced with sufficient dietary protein and resistance training (2).
Cardiovascular Strain: Hyperthyroidism increases heart rate and blood pressure, elevating the risk of arrhythmias and long-term cardiovascular complications (3).
Thyroid Suppression: Prolonged use of exogenous thyroid hormones suppresses the hypothalamic-pituitary-thyroid (HPT) axis, potentially leading to long-term dependency on medication (4).

Conclusion

Thyroid medication can be a useful tool for competitive bodybuilders in untested federations when used correctly. The key is to supplement physiological declines in thyroid function rather than to artificially push fat loss beyond natural metabolic limits. Misuse; especially using excessive doses, introducing it too early, or relying on it instead of proper dietary and training modifications poses significant risks. Competitors should prioritise a structured approach to dieting, use thyroid medication only when necessary, and carefully manage post-diet recovery to restore normal thyroid function.

References

St Germain DL, Galton VA, Hernandez A. Minireview: Defining the roles of the iodothyronine deiodinases: current concepts and challenges. Endocrinology. 2009;150(3):1097-1107.
Kim B. Thyroid hormone as a determinant of energy expenditure and the basal metabolic rate. Endocrine Regulations. 2008;42(2):67-72.
Biondi B, Kahaly GJ. Cardiovascular involvement in patients with different causes of hyperthyroidism. Nature Reviews Endocrinology. 2010;6(8):431-443.
Celi FS, Zemskova M, Linderman JD, et al. Metabolic effects of liothyronine therapy in hypothyroidism. The Journal of Clinical Endocrinology & Metabolism. 2011;96(11):3466-3474.

By approaching thyroid medication with a responsible, evidence-based strategy, bodybuilders can optimise performance while minimising health risks.